Alembic Pharma

875.00

-5.55 (-0.63%) tick

NSE

Buy Sell

NSE BSE

Last updated on 25 Apr 2025 03:33 PM

Open Demat account

Returns

3.08%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

17326.06

Earning Per Share

33.91

Dividend Yield

1.12%

P/E Ratio

28.97

P/B Ratio

3.44

Debt to Equity

0.13

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world. The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.

Similar Companies

Sun Pharmaceutical

1781.8 -22.10 (-0.01%) tick

1Yr Returns

+18.66%

Cipla

1525.1 -26.60 (-0.02%) tick

1Yr Returns

+10.34%

Mankind Pharma Limited

2557.5 -41.70 (-0.02%) tick

1Yr Returns

+8.36%

Dr. Reddys Laboratories

1174.8 -25.70 (-0.02%) tick

1Yr Returns

-3.47%

Lupin

2022 -82.10 (-0.04%) tick

1Yr Returns

+31.96%